Influence of left ventricular function on development of systolic anterior motion after mitral valve repair  by Manabe, Susumu et al.
Manabe et al Acquired Cardiovascular DiseaseA
C
DInfluence of left ventricular function on development of systolic
anterior motion after mitral valve repairSusumu Manabe, MD,a Hitoshi Kasegawa, MD,b Toshihiro Fukui, MD,b Minoru Tabata, MD, MPH,b
Tomohiro Shinozaki, MPH,c Tomoki Shimokawa, MD,a and Shuichiro Takanashi, MDbFrom th
Depa
partm
Disclos
Receive
publi
Address
Teiky
(E-m
0022-52
Copyrig
http://dxObjective: A hyperkinetic heart has been suggested as a risk factor for systolic anterior motion (SAM) after
mitral valve repair, but the influence of preoperative left ventricular (LV) function on the development of
SAM has not been elucidated.
Methods: Transthoracic echocardiographic data were retrospectively reviewed in 441 patients who underwent
mitral valve repair for degenerative mitral regurgitation. Comparisons were made between patients with and
without SAM (SAM cases vs noncases).
Results: The incidence of SAM was 6.1% (27/441). There were no differences in preoperative characteristics
and operative procedures between the 2 groups except the prevalence of Barlow disease. The SAM cases ex-
hibited a higher preoperative ejection fraction (EF) (SAM cases, 70.0%  7.1%; noncases, 65.1%  6.9%;
P<.01) and smaller preoperative systolic LV end-systolic dimension (LVDs) (32.0  5.4 mm vs 35.4  5.7
mm; P ¼ .02) than the noncases. The incidence of SAM was significantly associated with greater preoperative
EF (P<.01 for trend) and reduced LVDs (P<.01 for trend). SAM did not occur in patients with an impaired
(EF<60%) or enlarged (LVDs>45 mm) LV. The incidence of SAM was highest among patients with a small
hyperkinetic heart.
Conclusions: The study indicates that the development of SAM after mitral valve repair is associated with pre-
operative LV function. A small hyperkinetic heart is considered a risk factor for SAM and should be treated with
caution. (J Thorac Cardiovasc Surg 2013;146:291-5)Supplemental material is available online.
Systolic anterior motion (SAM) of mitral leaflets is a com-
mon complication that occurs in 8.4% to 9.8% of patients
who undergo mitral valve repair.1,2 In most cases SAM
resolves with conservative management,1,2 but some
patients experience hemodynamic collapse that requires
surgical correction.3,4 Thus, the possible postoperative
emergence of SAM is still a matter of concern and must
be managed appropriately by the surgeon who performed
the mitral valve operation.
The mechanism of SAM is consideredmultifactorial. Ac-
cording to Carpentier, Adams, and Filsoufi,5 the major risk
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The Journal of Thoracic and Caannular ring, whereas there are several minor risk factors,
such as a narrow aorta–mitral angle, abnormal configura-
tion of the anterior leaflet, and a small, hyperkinetic heart.
Previous studies have investigated the mechanism of
SAM mostly from a morphologic aspect,6-9 and there is
little known regarding the role of left ventricular (LV)
function. Several studies suggested that LV function also
has a bearing on the development of SAM,2,4,10 but these
suggestions were based on the surgeon’s impression rather
than a systematic analysis using objective data. Hence,
the purpose of this study was to investigate the influence
of LV function on the development of SAM after mitral
valve repair using transthoracic echocardiographic data.PATIENTS AND METHODS
Study Design
This retrospective cohort study investigated the hypothesis that preoper-
ative LV function affects the susceptibility to SAM after mitral valve repair.
Preoperative echocardiographic indices were compared between patients
with and without SAM. The Ethics Committee of Sakakibara Heart Insti-
tute approved this study, waived the need for patient consent, and provided
approval before the publication of the data.
Patient Population
Mitral valve repair for degenerative mitral regurgitation (MR) was
performed in 503 patients at the Sakakibara Heart Institute between January
2004 and December 2008. The exclusion criterion was concomitant perfor-
mance of other operative procedures, such as coronary artery bypass graft-
ing (n¼ 33), aortic valve replacement (n¼ 9), left ventriculoplasty (n¼ 3),rdiovascular Surgery c Volume 146, Number 2 291
Abbreviations and Acronyms
CI ¼ confidence interval
EF ¼ ejection fraction
LV ¼ left ventricular (ventricle)
LVDs ¼ systolic left ventricular dimension
MR ¼ mitral regurgitation
RR ¼ risk ratio
SAM ¼ systolic anterior motion
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Daortic aneurysm repair (n¼ 4), and repair of an atrial septal defect (n¼ 4).
Patients undergoing a concomitant maze procedure or tricuspid valve re-
pair were enrolled in this study. Among the remaining 450 patients, preop-
erative transthoracic echocardiography was recorded and available for 441
(98.0%) patients, whowere included in the study. Comparisons were made
between patients with and without SAM (SAM cases vs noncases).
Operative Strategy
The operation was performed by a median sternotomy, and cardiopul-
monary bypass was established with aortic and bicaval cannulation. Cold
antegrade and retrograde cardioplegia were used for myocardial protection.
The mitral valve was exposed through a superior transseptal approach. The
standard technique for valve repair was performed according to the ana-
tomic lesions responsible forMR. Chordal replacement with expanded pol-
ytetrafluoroethylene was used to repair an anterior mitral leaflet prolapse,
and quadrangular resection was used to repair a posterior mitral leaflet pro-
lapse. The sliding technique was used in patients with a posterior leaflet
prolapsed by more than 1.5 cm. Annuloplasty was performed in all except
3 study patients. A ring sizewas chosen according to the area of the anterior
leaflet, in line with the widely established techniques of mitral repair in de-
generative mitral disease. Residual MR was quantitatively assessed using
transesophageal echocardiography. Revision of repair was performed if
the MR area was more than 0.1 cm2.
Diagnosis and Management of SAM
Intraoperative transesophageal echocardiography was performed in all
patients undergoing mitral valve repair. SAM was defined as any portion
of the anterior mitral valve leaflet protruding into the LV outflow tract.
Patients with chordal SAM were excluded.
For patients in whom SAM developed intraoperatively, conservative
management was initially performed. This included discontinuing any
inotropic drugs, augmenting intravascular volume, and administering
b-blockade as tolerated. When SAM persisted after conservative manage-
ment, revision of the repair was performed. For most patients with SAM,
mitral annuloplasty was reevaluated to enlarge the mitral annulus. For pa-
tients with a semirigid prosthetic ring, upsizing of the prosthetic ring by 1
or 2 sizes was performed. For patients with an autologous pericardial band,
partial removal of the pericardial band was performed.
Definition of Barlow Disease
Barlow disease was defined when a patient possessed a valve with the
following characteristics: a billowing valve with excess tissue and thick-
ened leaflets; chords typically thickened and elongated; and a large valve
with severe annular dilatation.
Statistical Analysis
Differences between groups were compared using the c2 test for cate-
gorical variables and the Student t test for continuous variables. To assess
the effect of LV function on SAM, we calculated risk ratios (RR) and 95%
confidence intervals (CI) in contingency tables accompanied with the292 The Journal of Thoracic and Cardiovascular SurgCochrane-Armitage trend test. Multivariable logistic regression analysis
was performed to identify independent risk factors for development of
SAM. Variables with a univariate P value of less than .20 or those with
known biological significance were included in the multivariable model.
All statistical analyses were performed using SAS version 9.2 (SAS Insti-
tute, Inc, Cary, NC).RESULTS
Clinical Outcomes
There was no operative mortality among the study pa-
tients. There were 27 patients (21 male, 6 female; mean
age, 58.0  10.5 years) in whom SAM developed (SAM
cases), and 414 patients (280 male, 134 female; mean
age, 55.2  14.5 years) who had no SAM (noncases).
The incidence of SAM was 6.1%, and conservative man-
agement successfully resolved SAM in 15 of these patients.
Revision of valve repair at the initial operation was per-
formed in 12 patients, and SAM was resolved in 11; mitral
valve replacement was required in the other patient. Among
all 441 study patients, revision of repair at the initial oper-
ation was undertaken in 35 (7.9%), and 34.3% of the revi-
sions were performed as a result of SAM.
All SAM patients were discharged home without any
symptom. According to the transthoracic echocardiogram
at discharge, there was little or no residual MR in 23
(85.2%) SAM patients and mild MR in 4 (14.8%). SAM
persisted at discharge in 4 patients; 3 patients exhibited
mild MR associated with SAM and another patient was
free of recurrent MR. In noncases, there was little or no re-
sidual MR in 380 (91.8%) patients, mild MR in 32 (7.7%),
and moderate MR in 2 (0.5%).
Preoperative patient characteristics, the location of mitral
valve prolapse, and the operative procedures performed are
summarized in Table 1. There were no differences between
the 2 groups in preoperative patient characteristics, except
for the prevalence of Barlow disease. The prevalence of
SAM in patients with Barlow disease was 16.7% (Table
E1). A solitary anterior lesion was rare in the SAM cases
(1 patient), but the spectrum of valve lesions was not signif-
icantly different between the 2 groups. The performed oper-
ations were almost similar between the 2 groups. There
were no differences in patient characteristics, location of
mitral valve prolapse, and operative procedures between pa-
tients undergoing conservative treatment for SAM and
those undergoing surgical treatment (Table E2).Influence of Preoperative LV Function on the
Development of SAM
The results of preoperative transthoracic echocardiogra-
phy in the 2 groups are compared in Table 2. The SAM cases
had significantly smaller systolic LV dimension (LVDs),
thicker interventricular septum, and greater ejection fraction
(EF). The incidence risks of SAM according to preoperative
EF and LVDs, aswell as RRwith 95%CI in each category toery c August 2013
TABLE 1. Patient characteristics, location of mitral valve prolapse,
and operative procedures
SAM cases
(n ¼ 27)
Noncases
(n ¼ 414)
P
value
Age (y) 58.0  10.5 55.2  14.5 .20
Male 21 (77.8%) 280 (67.6%) .39
NYHA class 1.6  0.7 1.9  0.8 .06
Hypertension 7 (25.9%) 122 (29.5%) .83
Hyperlipidemia 2 (7.4%) 41 (9.9%) 1.00
Atrial fibrillation 6 (22.2%) 125 (30.2%) .52
Location of mitral valve prolapse .08
Anterior leaflet 1 (3.7%) 78 (18.8%)
Posterior leaflet 19 (70.4%) 215 (51.9%)
Both leaflets 7 (25.9%) 121 (29.2%)
Barlow disease 7 (25.9%) 35 (8.5%) <.01
Operative procedures
Leaflet resection 23 (85.2%) 338 (81.6%) .80
With sliding technique 11 (40.7%) 121 (29.2%)
Chordal replacement 14 (51.9%) 253 (61.1%) .42
Types of artificial ring .18
Semirigid ring 16 (59.3%) 300 (72.5%)
Flexible ring 11 (40.7%) 111 (26.8%)
Tailor ring 2 24
Duran ring 2 28
Autologous pericardial band 7 58
Cosgrove band 0 1
None 0 3 (0.7%)
Ring size 29.9  2.2 29.7  3.0 .74
Additional procedure
Maze 4 (14.8%) 78 (18.8%) .80
Tricuspid valve repair 3 (11.1%) 53 (12.8%) 1.00
Data are shown as mean  standard deviation or n (%). SAM, Systolic anterior mo-
tion; NYHA, New York Heart Association.
TABLE 3. Incidence of SAM according to preoperative ejection
fraction and left ventricular end-systolic dimension
Ejection fraction (%)
SAM
case
No.
at risk Risk RR* 95% CI
Ejection fraction (%)
49 0 9 0.0%
50-54 0 16 0.0%
55-59 0 51 0.0%
60-64y 6 118 5.1% 1.00 Reference
65-69 8 134 6.0% 1.17 0.42-3.29
70-74 7 81 8.6% 1.70 0.59-4.87
75þ 6 32 18.8% 3.69 1.27-10.67
End-systolic
diameter (mm)
46 0 16 0.0%
41-45 1 47 2.1% 0.52 0.06-4.19
36-40y 6 146 4.1% 1.00 Reference
31-35 10 159 6.3% 1.53 0.57-4.11
26-30 7 58 12.1% 2.94 1.03-8.37
25 3 15 20.0% 4.87 1.35-17.5
SAM, Systolic anterior motion; RR, risk ratio; CI, confidence interval. *Risk ratio
compared to reference category. yReference category.
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curred in patients with LV dysfunction (EF<60%). The in-
cidence of SAM increased with greater preoperative EF
(P<.01 for trend). Similarly, no SAM occurred in patients
with an enlarged LV (LVDs> 46 mm). The incidence of
SAM increased as the preoperative LVDs became smaller
(P< .01 for trend). The distribution of preoperative EF
and LVDs in the 2 groups is shown in Figure 1.Most patients
(26/27) in the SAM group exhibited well-preserved LV
function (EF  60% and LVDs<40 mm).TABLE 2. Preoperative echocardiographic data
SAM cases (n ¼ 27) Noncases (n ¼ 414) P value
LAD (mm) 44.6  8.2 46.8  7.8 .16
LVDd (mm) 54.9  5.6 56.6  6.1 .17
LVDs (mm) 32.0  5.4 35.4  5.5 <.01
IVS (mm) 10.8  1.5 10.0  1.1 <.01
LVPW (mm) 10.4  1.2 10.0  1.1 .06
EF (%) 70.0  7.1 65.1  6.9 <.01
P values set in italics indicate statistical significance. SAM, Systolic anterior motion;
LAD, left atrial dimension; LVDd, diastolic left ventricular dimension; LVDs, systolic
left ventricular dimension; IVS, interventricular septum; LVPW, left ventricular
posterior wall; EF, ejection fraction.
The Journal of Thoracic and CaThe incidence of SAM among the highest risk group
(EF 75% and LVDs 25mm) was 37.5%. The operative
procedures performed for these patients were similar to
those performed for the other patients, except for the
more frequent use of sliding technique (50.0%) and flexible
ring (62.5%). Patients with a small hyperkinetic heart re-
ceived a smaller annular ring than the other patients (28.8
mm vs 29.8 mm).
The results of multivariable analysis are shown in Table
4. A posterior leaflet lesion, Barlow disease, performance
of the sliding leaflet technique, use of a semirigid ring,
ring size, thickness of the interventricular septum, and EF
were incorporated into the analysis. Interventricular septum
thickness and EF were independent predictors for the devel-
opment of SAM.FIGURE 1. Distribution of preoperative ejection fractions and left
ventricular dimensions in the 2 groups. White and black squares represent
patients with and without systolic anterior motion, respectively.
rdiovascular Surgery c Volume 146, Number 2 293
TABLE 4. Multivariable predictors of the development of SAM
Variable Odds ratio 95% CI P value
Posterior leaflet lesion 4.77 0.59-38.8 .14
Barlow’s disease 3.17 0.94-10.6 .06
Sliding leaflet technique 0.84 0.32-2.19 .72
Semi rigid ring 0.87 0.35-2.20 .77
Ring size (1 mm) 1.07 0.91-1.25 .42
IVS (1 mm) 1.60 1.15-2.21 <.01
EF (5%) 1.66 1.19-2.31 <.01
P values set in italics indicate statistical significance. SAM, Systolic anterior motion;
CI, confidence interval; IVS, interventricular septum; EF, ejection fraction.
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that SAM cases had smaller LVDs (30.9  5.4 mm vs
34.7  6.5 mm) and greater EF (58.0%  10.5% vs
53%.5  9.6%) than noncases.
DISCUSSION
The present study revealed a close relationship between
the development of SAM and preoperative LV function in
patients undergoing mitral valve repair. No SAM developed
in patients with an impaired or enlarged LV. The incidence
of SAM increased with LV hyperkinesia. In the group with
the highest risk of SAM (EF  75% and LVDs  25 mm),
the incidence of SAM was as high as 37.5%.
The contribution of LV function to the development of
SAM has been discussed in several reports. Freeman and as-
sociates10 attributed SAM to the hyperdynamic state caused
by post–cardiopulmonary bypass hypovolemia in combina-
tion with catecholamine infusion. Braun and coworkers2 re-
ported that most SAM could be managed by conservative
treatment consisting of volume expansion and discontinua-
tion of inotropic drug therapy. Rescigno and colleagues4 re-
ported a rare case of late development of SAM. In this
patient, SAM emerged on recovery of LV function that
had temporarily deteriorated immediately after surgery.
These studies suggested that there was a relationship be-
tween LV function and the development of SAM, but the as-
sociation was mainly based on the impression of the
surgeons rather than on a systematic demonstration using
objective data. Data analyzed in the present study demon-
strated a close relationship between preoperative LV func-
tion and the incidence of SAM.
Although the present study revealed that preoperative LV
function was associated with susceptibility to SAM, it did
not deny a contribution ofmitral valve structure or procedural
modification to the development of SAM. Preoperative LV
function was not the only determinant in the development
of SAM. In the highest risk group (EF  75% and
LVDs  25 mm), about two thirds of patients did not have
SAM, suggesting that the mechanism leading to SAM is mul-
tifactorial. The present study also suggested another possible
risk factor for SAM. In patients with a solitary anterior lesion,
the incidence of SAM was low, although the differences did294 The Journal of Thoracic and Cardiovascular Surgnot reach statistical significance. There were no differences
in preoperative LV function between patients with a solitary
anterior lesion and the other patients (LVDs, 36.3  5.6 mm
vs 35.0  5.5 mm; EF, 63.9%  6.5% vs 65.7%  7.1%).
Patients with a solitary anterior lesion underwent posterior
leaflet resection less frequently (0%vs93.6%). Posterior leaf-
let resection might immobilize the posterior leaflet motion
and fix it at the closed position, which might bring the coap-
tation point closer to the LVoutflow tract and predispose the
mitral valve toward developing SAM. Patients with Barlow
disease also exhibited a high risk of SAM, although the
difference did not reach statistical significance in multivari-
able analysis. However, our study did not include the mea-
surement of the leaflet length, which made it difficult to
precisely analyze the relationship between leaflet length
and the risk of SAM.
The findings of the present study may attain further impor-
tance in the modern era of mitral valve surgery. According to
the current American College of Cardiology/American
Heart Association guidelines, surgical correction is recom-
mended for patients with severe mitral regurgitation before
the emergence of early signs of LV deterioration.11 Several
studies demonstrated superior results with ‘‘early surgery’’
compared with ‘‘conventional treatment.’’12,13 Therefore,
increasing numbers of patients with well-preserved LV func-
tion are now undergoing mitral valve surgery. According to
our results, the risk of SAM was only 0.96% (1/104) in
patients with LV dysfunction and who are recommended
to receive a ‘‘conventional treatment’’ strategy. However,
the risk of SAM was 7.7% (26/337) in ‘‘early surgery’’
patients. Therefore, surgeons in the modern era of mitral
valve surgerymust be skilled inmanaging this complication.
The present study revealed that a small hyperkinetic heart
is a risk factor for SAM. Considering the high incidence of
SAM, a small hyperkinetic heart should be treated with cau-
tion. We routinely administered catecholamine at bypass
discontinuation, which may have contributed to the devel-
opment of SAM and should be avoided in patients with
a hyperkinetic heart. In this study, patients with a small hy-
perkinetic heart received a smaller annular ring than the
other patients. At the revision of the repair, we upsized the
prosthetic ring by 1 or 2 sizes to eliminate SAM. A ring
size is considered the culprit in the development of SAM,
and a small ring should be avoided for patients with a small
hyperkinetic heart. Other preventive procedures14,15 may
also be required, not only in patients with a high posterior
leaflet, but also in patients with a hyperkinetic LV.
Study Limitations
This study has several limitations. First, all data were ret-
rospectively collected; therefore, we cannot eliminate the
possibility of confounding bias in the interpretation of the
data. We carried out procedures to correct for morphologic
characteristics that may predispose some mitral valves toery c August 2013
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the contribution of these characteristics. We could not in-
corporate some variables into multivariate analysis, includ-
ing aorta–mitral angle, the length of the anterior leaflet, and
the existence of a sigmoid septum, which might have an in-
fluence on the susceptibility to the development of SAM.
Some data on cardiac chamber parameters in this study
may seem small compared with those from Western coun-
tries, but this is likely related to the small physiques of
the Japanese compared with those of Western populations.
Such differences in physique must be considered in the in-
terpretation of our data.References
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TABLE E1. Incidence of SAM according to patient and operative
characteristics
Characteristics
Incidence of SAM
With characteristics Without characteristics
Posterior lesion 7.2% 1.3%
Barlow disease 16.7% 5.0%
Sliding leaflet resection 8.3% 5.2%
Chordal replacement 5.2% 7.5%
Semirigid ring 5.1% 8.8%
SAM, Systolic anterior motion.
TABLE E2. Comparisons between conservative and surgical
treatment in SAM cases
Conservative
treatment
(n ¼ 15)
Surgical
treatment
(n ¼ 12)
P
value
Age (y) 57.5  9.3 58.7  12.2 .78
Male 12 (80.0%) 9 (75.0%) 1.00
Location of mitral valve
prolapse
Anterior leaflet 1 (6.7%) 0 (0%) .10
Posterior leaflet 10 (66.7%) 9 (75.0%)
Both leaflets 4 (26.7%) 3 (25.0%)
Barlow disease 3 (20.0%) 4 (33.3%) .66
Operative procedures
Leaflet resection 11 (73.3%) 12 (100%) .11
With sliding technique 8 (53.3%) 5 (41.7%)
Chordal replacement 6 (40.0%) 6 (50.0%) 1.00
Types of artificial ring 1.00
Semirigid ring 9 (60.0%) 7 (58.3%)
Flexible ring 6 (40.0%) 5 (41.7%)
Ring size 30.1  2.1 29.8  2.3 .72
LAD (mm) 43.5  8.0 46.1  8.6 .43
LVDd (mm) 54.7  4.7 55.2  6.7 .83
LVDs (mm) 32.5  4.0 31.4  7.0 .63
IVS (mm) 10.7  1.8 10.8  1.2 .94
LVPW (mm) 10.3  1.2 10.6  1.1 .52
EF (%) 67.9  4.8 72.6  8.7 .11
Data are shown as mean  standard deviation or n (%). SAM, Systolic anterior
motion; LAD, left atrial dimension; LVDd, diastolic left ventricular dimension;
LVDs, systolic left ventricular dimension; IVS, interventricular septum; LVPW, left
ventricular posterior wall; EF, ejection fraction.
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